These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15965590)

  • 1. Drug release from cast films of ethylene vinyl acetate (EVA) copolymer: Stability of drugs by 1H NMR and solid state 13C CP/MAS NMR.
    Kalachandra S; Lin DM; Stejskal EO; Prakki A; Offenbacher S
    J Mater Sci Mater Med; 2005 Jul; 16(7):597-605. PubMed ID: 15965590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
    Tallury P; Alimohammadi N; Kalachandra S
    Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymeric device for delivery of anti-microbial and anti-fungal drugs in the oral environment: effect of temperature and medium on the rate of drug release.
    Lin DM; Kalachandra S; Valiyaparambil J; Offenbacher S
    Dent Mater; 2003 Nov; 19(7):589-96. PubMed ID: 12901982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability and release of antiviral drugs from ethylene vinyl acetate (EVA) copolymer.
    Kalachandra S; Takamata T; Lin DM; Snyder EA; Webster-Cyriaque J
    J Mater Sci Mater Med; 2006 Dec; 17(12):1227-36. PubMed ID: 17143753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EVA copolymer matrix for intra-oral delivery of antimicrobial and antiviral agents.
    Ramadevi A; Padmavathy T; Stigall G; Paquette D; Kalachandra S
    J Mater Sci Mater Med; 2008 Feb; 19(2):721-7. PubMed ID: 17619973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of solubilizing surfactants and loading of antiviral, antimicrobial, and antifungal drugs on their release rates from ethylene vinyl acetate copolymer.
    Tallury P; Randall MK; Thaw KL; Preisser JS; Kalachandra S
    Dent Mater; 2007 Aug; 23(8):977-82. PubMed ID: 17049593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled drug release for oral condition by a novel device based on ethylene vinyl acetate (EVA) copolymer.
    Kalachandra S; Dongming L; Offenbacher S
    J Mater Sci Mater Med; 2002 Jan; 13(1):53-8. PubMed ID: 15348205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and properties of partially hydrolyzed ethylene vinyl acetate copolymer films for controlled drug release.
    Tang M; Hou J; Lei L; Liu X; Guo S; Wang Z; Chen K
    Int J Pharm; 2010 Nov; 400(1-2):66-73. PubMed ID: 20804834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of antimicrobial and antiviral drugs from methacrylate copolymer system: effect of copolymer molecular weight and drug loading on drug release.
    Tallury P; Airrabeelli R; Li J; Paquette D; Kalachandra S
    Dent Mater; 2008 Feb; 24(2):274-80. PubMed ID: 17628658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity and local release characteristics of chlorhexidine diacetate loaded within the dental copolymer matrix, ethylene vinyl acetate.
    Arnold RR; Wei HH; Simmons E; Tallury P; Barrow DA; Kalachandra S
    J Biomed Mater Res B Appl Biomater; 2008 Aug; 86(2):506-13. PubMed ID: 18335433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release of 5-fluorouridine from radiation-crosslinked poly(ethylene-co-vinyl acetate) films.
    de Queiroz AA; Abraham GA; Higa OZ
    Acta Biomater; 2006 Nov; 2(6):641-50. PubMed ID: 16876492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
    Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release characteristics of quinupramine from the ethylene-vinyl acetate matrix.
    Kim J; Kim WJ; Kim SJ; Cho CW; Shin SC
    Int J Pharm; 2006 Jun; 315(1-2):134-9. PubMed ID: 16644151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of ethylene vinyl acetate copolymers (EVA) in drug delivery systems.
    Schneider C; Langer R; Loveday D; Hair D
    J Control Release; 2017 Sep; 262():284-295. PubMed ID: 28789964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTIR imaging for the characterization of controlled-release drug delivery applications.
    Rafferty DW; Koenig JL
    J Control Release; 2002 Sep; 83(1):29-39. PubMed ID: 12220836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calibration models for the vinyl acetate concentration in ethylene-vinyl acetate copolymers and its on-line monitoring by near-infrared spectroscopy and chemometrics: use of band shifts associated with variations in the vinyl acetate concentration to improve the models.
    Watari M; Ozaki Y
    Appl Spectrosc; 2005 Jul; 59(7):912-9. PubMed ID: 16053563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of atenolol from the ethylene-vinyl acetate matrix.
    Kim J; Shin SC
    Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems.
    Shin SC; Lee HJ
    Eur J Pharm Biopharm; 2002 Sep; 54(2):201-6. PubMed ID: 12191692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of dissolution induced changes in film coat composition by 1H NMR spectroscopy and SEM.
    Strübing S; Metz H; Syrowatka F; Mäder K
    J Control Release; 2007 Jun; 119(2):190-6. PubMed ID: 17434640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion.
    Almeida A; Possemiers S; Boone MN; De Beer T; Quinten T; Van Hoorebeke L; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2011 Feb; 77(2):297-305. PubMed ID: 21168487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.